- Home
- JAZZ vs VOYA Comparison
JAZZ vs VOYA Comparison
Compare JAZZ & VOYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- VOYA
- Stock Information
- Founded
- JAZZ 2003
- VOYA 1975
- Country
- JAZZ Ireland
- VOYA United States
- Employees
- JAZZ N/A
- VOYA N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- VOYA Life Insurance
- Sector
- JAZZ Health Care
- VOYA Finance
- Exchange
- JAZZ Nasdaq
- VOYA Nasdaq
- Market Cap
- JAZZ 8.1B
- VOYA 6.7B
- IPO Year
- JAZZ 2007
- VOYA 2013
- Fundamental
- Price
- JAZZ $136.01
- VOYA $71.95
- Analyst Decision
- JAZZ Strong Buy
- VOYA Buy
- Analyst Count
- JAZZ 14
- VOYA 12
- Target Price
- JAZZ $177.50
- VOYA $82.55
- AVG Volume (30 Days)
- JAZZ 688.4K
- VOYA 1.0M
- Earning Date
- JAZZ 02-25-2025
- VOYA 02-04-2025
- Dividend Yield
- JAZZ N/A
- VOYA 2.50%
- EPS Growth
- JAZZ 458.10
- VOYA 13.84
- EPS
- JAZZ 7.04
- VOYA 6.17
- Revenue
- JAZZ $3,992,712,000.00
- VOYA $8,050,000,000.00
- Revenue This Year
- JAZZ $7.53
- VOYA N/A
- Revenue Next Year
- JAZZ $6.94
- VOYA $5.31
- P/E Ratio
- JAZZ $19.42
- VOYA $11.92
- Revenue Growth
- JAZZ 5.23
- VOYA 9.55
- 52 Week Low
- JAZZ $99.06
- VOYA $64.10
- 52 Week High
- JAZZ $138.27
- VOYA $84.30
- Technical
- Relative Strength Index (RSI)
- JAZZ 68.46
- VOYA 49.06
- Support Level
- JAZZ $134.56
- VOYA $72.56
- Resistance Level
- JAZZ $138.27
- VOYA $76.02
- Average True Range (ATR)
- JAZZ 3.56
- VOYA 2.16
- MACD
- JAZZ 1.17
- VOYA 0.14
- Stochastic Oscillator
- JAZZ 88.20
- VOYA 62.41
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About VOYA Voya Financial Inc.
Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Wealth Solutions, Investment Management, and Health Solutions The Wealth segment generates roughly half of the company's revenue.